HCW Biologics Inc.
Organization details
- Legal name
- HCW Biologics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Miramar
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HCWB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001828673
- EIN
- 82-5024477
Board of directors
-
Gary M. Winer · DirectorSince 2023
-
Hing C. Wong · Director · Chief Executive OfficerSince 2023
-
Lisa M. Giles · DirectorSince 2023
-
Rick S. Greene · DirectorSince 2023
-
Scott T. Garrett · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 15, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.0%
-
83.0%
Board connections
2 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
LENSAR Inc. Same sectorvia Gary M. Winer
-
Milestone Pharmaceuticals Inc. Same sectorvia Lisa M. Giles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $531,717
- 6 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Flowers Lee Officer (SVP of Business Development) | Open-market purchase | +7,736 | $2.59 | $20,036 |
| Jul 29, 2026 | Scott T. Garrett Director | Open-market purchase | +7,736 | $2.59 | $20,036 |
| Jul 29, 2026 | Hing C. Wong Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +23,210 | $2.59 | $60,114 |
| May 22, 2026 | Hing C. Wong Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +113,879 | $1.41 | $160,569 |
| May 22, 2026 | Scott T. Garrett Director | Open-market purchase | +177,936 | $1.41 | $250,890 |
| May 22, 2026 | Byam Rebecca Officer (Chief Financial Officer) | Open-market purchase | +14,235 | $1.41 | $20,071 |
| May 16, 2025 | Hing C. Wong Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +8,054 | $7.45 | $60,002 |
| May 16, 2025 | Gary M. Winer Director | Open-market purchase | +1,342 | $7.45 | $9,998 |
| May 16, 2025 | Scott T. Garrett Director | Open-market purchase | +13,423 | $7.45 | $100,001 |
| May 8, 2025 | Gary M. Winer Director | Open-market purchase | +2,308 | $26.00 | $60,008 |
| May 8, 2025 | Hing C. Wong Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +92,500 | $26.00 | $2,405,000 |
| May 8, 2025 | Scott T. Garrett Director | Open-market purchase | +5,385 | $26.00 | $140,010 |
| May 8, 2025 | Byam Rebecca Officer (Chief Financial Officer) | Open-market purchase | +8,462 | $26.00 | $220,012 |
| May 8, 2025 | Flowers Lee Officer (SVP of Business Development) | Open-market purchase | +962 | $26.00 | $25,012 |
| May 8, 2025 | Rick S. Greene Director | Open-market purchase | +962 | $26.00 | $25,012 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about HCW Biologics Inc.
Who is the CEO of HCW Biologics Inc.?
Hing C. Wong is HCW Biologics Inc.'s Chief Executive Officer.
How many directors are on HCW Biologics Inc.'s board?
HCW Biologics Inc.'s board has 5 directors: Gary M. Winer, Hing C. Wong, Lisa M. Giles, Rick S. Greene and Scott T. Garrett.
Are HCW Biologics Inc. insiders buying or selling shares?
Over the last 12 months, HCW Biologics Inc. insiders bought $531,717 of shares in 6 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="hcw-biologics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.